Corcept Therapeutics Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2023
Total Assets: $621.5M
Liabilities Breakdown FY2023
Total Liabilities: $114.8M
Asset Breakdown
Total Assets: $621.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $135.6M | 21.8% |
| Accounts Receivable | $41.1M | 6.6% |
| Inventory | $7.7M | 1.2% |
| Property, Plant & Equipment | $195.0K | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $436.9M | 70.3% |
Liabilities Breakdown
Total Liabilities: $114.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $17.4M | 15.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $97.4M | 84.8% |